Peter Benotti
Overview
Explore the profile of Peter Benotti including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
704
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wood G, Hoovler A, Luthra R, Still C, Shariff H, Still M, et al.
Expert Rev Gastroenterol Hepatol
. 2025 Mar;
PMID: 40067340
Background: Using common clinical parameters, we aimed to noninvasively identify and predict metabolic dysfunction - associated steatohepatitis (MASH)/MASH with clinically significant fibrosis. Research Design And Methods: Patients aged ≥ 18...
2.
Yasuo T, Wood G, Chu X, Benotti P, Still C, Rolston D, et al.
J Oral Biosci
. 2022 Jan;
64(1):155-158.
PMID: 34979250
Taste-signaling proteins, which are expressed throughout the digestive tract, are involved in regulating metabolism and immunity. This study aimed to determine if these genes are expressed and altered in jejunal...
3.
Wood G, Bailey-Davis L, Benotti P, Cook A, Dove J, Mowery J, et al.
PLoS One
. 2021 Nov;
16(11):e0258545.
PMID: 34731171
Objective: Determine the impact of long-term non-surgical weight loss maintenance on clinical relevance for osteoarthritis, cancer, opioid use, and depression/anxiety and healthcare resource utilization. Methods: A cohort of adults receiving...
4.
Bailey-Davis L, Wood G, Benotti P, Cook A, Dove J, Mowery J, et al.
Am J Cardiol
. 2021 Oct;
162:66-72.
PMID: 34702552
Obesity increases the risk of developing type 2 diabetes, hypertension, and hyperlipidemia. We sought to determine the impact of obesity maintenance, weight regain, weight loss maintenance, and magnitudes of weight...
5.
Lee C, Wood G, Bressler N, Govina T, Lazo M, Brown T, et al.
Obes Surg
. 2019 Feb;
29(7):2126-2131.
PMID: 30805857
Objective: We sought to validate an algorithm designed to identify patients with post-gastric bypass hypoglycemia (PGBH) using clinician chart review. Methods: We conducted a chart review study of non-diabetic patients...
6.
Still C, Benotti P, Mirshahi T, Cook A, Wood G
Surg Obes Relat Dis
. 2019 Jan;
15(5):717-724.
PMID: 30686670
Background: DiaRem is a validated tool for predicting the likelihood of type 2 diabetes (T2D) remission after Roux-en-Y gastric bypass (RYGB) surgery. Objectives: The objective of this study was to...
7.
McCracken E, Wood G, Prichard W, Bistrian B, Still C, Gerhard G, et al.
Surg Obes Relat Dis
. 2018 May;
14(7):902-909.
PMID: 29735346
Background: The current popularity of metabolic surgery has led to increasing attention to long-term nutritional complications. Objective: The purpose of this retrospective study is to accurately define the long-term incidence...
8.
Chu X, Jin Q, Chen H, Wood G, Petrick A, Strodel W, et al.
J Transl Med
. 2018 Apr;
16(1):108.
PMID: 29690903
Background: Nonalcoholic fatty liver disease (NAFLD) is a prevalent complication of extreme obesity. Loading of the liver with fat can progress to inflammation and fibrosis including cirrhosis. The molecular factors...
9.
Wood G, Horwitz D, Still C, Mirshahi T, Benotti P, Parikh M, et al.
Obes Surg
. 2017 Jul;
28(1):61-68.
PMID: 28717860
Objective: The objective of this study was to determine whether the DiaRem, a score that predicts type 2 diabetes (T2D) remission following roux-en-y gastric bariatric surgery (RYGB), also predicts remission...
10.
Wood G, Chu X, Argyropoulos G, Benotti P, Rolston D, Mirshahi T, et al.
Sci Rep
. 2017 Mar;
7:43238.
PMID: 28266614
Non-alcoholic fatty liver disease (NAFLD) represents a spectrum of conditions that include steatohepatitis and fibrosis that are thought to emanate from hepatic steatosis. Few robust biomarkers or diagnostic tests have...